Welcome
Enabling drug release from medical devices
PolyActiva Pty Ltd uses a unique drug-polymer conjugate technology to enable site specific drug delivery from medical device components, such as implants, films, or fibers.
**PRESS RELEASE: November 2020 – PolyActiva Pty Ltd, a clinical-stage Australian ophthalmology biopharmaceutical company, announced it has successfully completed its Phase I clinical study for its lead candidate, the Latanoprost FA SR Ocular Implant....read more…